The solute carrier MFSD1 decreases β1 integrins activation status and thus tumor metastasis
M. Roblek, J. Bicher, M. van Gogh, A. Gyoergy, R. Seeboeck, B. Szulc, M. Damme, M. Olczak, L. Borsig, D. Siekhaus
This study shows that MFSD1 reduces β1 integrin activation, thereby suppressing tumor metastasis in a mouse model.
bioRxiv · Sep 17, 2021Cancer Biology